| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/11/2006 | EP1614422A2 Ibandronate for the promotion of osseointegration of endoprostheses |
| 01/11/2006 | EP1614418A1 use of(-)(3-trihalomethylphenoxy) (4-halophenyl)acetic acid derivatives for treatment of hyperuricaemia |
| 01/11/2006 | EP1613662A2 Novel method of obtaining chondroitin sulphuric acid and uses thereof |
| 01/11/2006 | EP1613588A2 2-propylidene-19-nor-vitamin d compounds |
| 01/11/2006 | EP1613300A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 01/11/2006 | EP1613273A2 Recombinant il-9 antibodies and uses thereof |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | EP1613267A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1421082B1 piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1131310B1 Chrystals of 5- 6-(2-fluorobenzyl)oxy-2-naphthyl methyl]-2,4-thiazolidinedione |
| 01/11/2006 | EP1127064B1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | CN1720057A Chinese patent medicine for treating baldness and preparing process thereof |
| 01/11/2006 | CN1720040A Remedy |
| 01/11/2006 | CN1718735A Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 01/11/2006 | CN1718714A Colourless transparent health care wine for knocks and falls and its preparation method |
| 01/11/2006 | CN1718578A Lerivisiticum extract, its preparation method and medicine containing said extract |
| 01/11/2006 | CN1718573A Heterocyclic compound |
| 01/11/2006 | CN1718223A Medicine for treating osteoporosis contg. astraglus base and stanozolol |
| 01/11/2006 | CN1718218A Medicine for treating osteoarthritis, and its prepn. method |
| 01/11/2006 | CN1718212A Plaster for treating diseases of muscles and bones, and its prepn. method |
| 01/11/2006 | CN1718211A Traditional Chinese emdicine compounding prepns. for treating fracture |
| 01/11/2006 | CN1718210A External use drugs for treating injuries from falls, fracture, contusions and strains |
| 01/11/2006 | CN1718200A Ointment used for anti-hyperosteogeny, and its prepn. method |
| 01/11/2006 | CN1718190A Nux vomica alkaloid liposome, and its prepn. method |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235635C Medicine for treating osteosis |
| 01/11/2006 | CN1235630C Chinese medicine paste for curing osteoarthropathy and preparing method |
| 01/11/2006 | CN1235623C Naturally curing fracture setting pill |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/11/2006 | CN1235578C Fumaric acid microtablets |
| 01/10/2006 | US6984667 Synergistic proteoglycan compositions for inflammatory conditions |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984405 Compositions for inducing secretion of insulin-like growth factor-1 |
| 01/10/2006 | CA2406745C A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2299760C Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006000577A2 Lxr agonists to promote bone homeostasis |
| 01/05/2006 | WO2006000224A2 Compositions comprising strontium and vitamin d and uses thereof |
| 01/05/2006 | WO2004017908A3 Calcium receptor modulating compound and use thereof |
| 01/05/2006 | US20060004456 Intervertebral disc treatment devices and methods |
| 01/05/2006 | US20060004104 Use of 5-alkyl substituted 2-arylaminophenylacetic acid derivatives as selective cyclooxygenase-2 inhibitors in the treatment of cancer pain, especially bone cancer pain; for example, 5-methyl-2-(2'-chloro-6'-fluoroanilino)-phenylacetic acid |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | US20060004077 Inhibiting class II MHC-mediated activation of T cells; peptidomimetics of given sequence which include a Gpg (guanylpiperidyl glycine) unit; rheumatoid arthritis and/or multiple sclerosis; e.g. Ac-Cha-Gpg-Tic-Nle-NHCH2CH2Ph (Cha=cyclohexylalanine, Tic=3-carboxyisoquinoline, Nle=norleucine) |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004056 Di-aryl-substituted-ethan pyridone pde4 inhibitors |
| 01/05/2006 | US20060004051 Compounds |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004030 Asthma, antiallergens; rheumatoid arthritis and atherosclerosis; anticarcinogenic agents; 2-(Benzylthio)-6-{[(1R)-2-hydroxy-1-methylethyl]amino}-4-pyrimidinol |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004028 Novel PARP inhibitor |
| 01/05/2006 | US20060004025 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004010 Ccr4 antagonist and medical use thereof |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003996 Intralesional treatment of psoriasis |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003975 Combination of an aldosterone receptor antagonist and an HMG CoA reductase inhibitor |
| 01/05/2006 | US20060003973 Use of 2alpha-methyl-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 01/05/2006 | US20060003955 Immunostimulatory nucleic acid molecules |
| 01/05/2006 | US20060003954 Inhibiting the expression of a wild type COL1A1 gene to treat a lung disease relating to a collagen disorder |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003922 Spinner preparation machine and cavity resonator |
| 01/05/2006 | US20060003410 Oxidoreductase for use in identifying modulators for prevention and treatment of diabetes, obesity, dyslipidemia, coronary heart, inflammatory and cancer disorders |
| 01/05/2006 | US20060002979 Multifunctional biodegradable composite and surgical implant comprising said composite |
| 01/05/2006 | US20060002930 Treatment of disorders |
| 01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
| 01/05/2006 | US20060002908 Bifidobacterium in the treatment of inflammatory disease |
| 01/05/2006 | US20060002901 Composition containing eosinophil cationic protein |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | CA2571656A1 Methods and crosslinked polymer compositions for cartilage repair |
| 01/05/2006 | CA2571449A1 Compositions comprising strontium and vitamin d and uses thereof |
| 01/05/2006 | CA2571433A1 Solid and crystalline ibandronic acid |
| 01/05/2006 | CA2571087A1 Novel piperidine derivates as modulators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570615A1 Drugs for treating duplication of hypertension with hyperuricemia and /or hypercholesterolemia |
| 01/05/2006 | CA2568857A1 Lxr agonists to promote bone homeostasis |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | EP1612266A2 Prostaglandin reductase |
| 01/04/2006 | EP1611901A1 Preventive or remedy for teeth grinding |
| 01/04/2006 | EP1611900A1 Method of treating inflammtory disease associated with bone destruction |
| 01/04/2006 | EP1611887A2 Modulation of peroxisome proliferator-activated receptors |
| 01/04/2006 | EP1611143A2 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 01/04/2006 | EP1611124A1 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
| 01/04/2006 | EP1610864A1 Electromagnetic stimulation in patients with osteoporosis |
| 01/04/2006 | EP1610814A1 Therapeutic composition for autoimmune conditions |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |